Clinical Trial Update: Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and tolerability of the combination of voreloxin and cytarabine in adults with acute myeloid leukemia; trial co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Voreloxin (vosaroxin)

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-09